症状性颈动脉血运重建术后结局的性别差异:多中心队列研究
该回顾性多中心队列研究纳入2016至2026年间822例症状性颈动脉狭窄患者,比较男性和女性在颈动脉内膜剥脱术、经颈动脉血运重建或经股动脉颈动脉支架置入术后30天及长期结局。结果显示,男女在30天和长期卒中、TIA、心肌梗死、死亡、再狭窄及再干预的复合或单独结局上均无统计学显著差异,倾向性评分匹配后结论一致。
要点
- 症状性颈动脉狭窄患者中,男女血运重建术后30天和长期结局无显著差异。
- 女性总胆固醇、HDL及LDL较高,但LDL/HDL比值无显著差异。
- 倾向性评分匹配后,高危斑块特征人群的短期和长期结局仍无性别差异。
核心结论
- 在三个高容量卒中中心十年期间,CEA、TCAR或TFCAS术后30天及长期结局未发现统计学显著的性别差异。
- 对具有易损斑块特征的高危人群进行倾向性评分匹配后,短期和长期结局仍未受性别影响。
研究设计与样本
- 回顾性研究,纳入2016至2026年间连续病例,共822例手术(男性571例,69.5%;女性251例,30.5%),平均年龄73.2±9.2岁。
- 纳入因同侧颈动脉狭窄导致卒中、TIA或一过性黑矇且在术前6个月内行CEA、TCAR或TFCAS的患者,排除既往颈部放疗者。
- 对具备MRA血管壁成像的患者进行1:1倾向性评分匹配分析(男性91例,女性91例,N=182)。
主要发现
- 30天复合终点(卒中、TIA、MI、死亡)男性4.2% vs 女性4.0%(p=0.88),同侧卒中2.5% vs 1.6%(p=0.61),TIA 0.7% vs 1.6%(p=0.23),MI 0.5% vs 0.0%(p=0.25),死亡0.5% vs 1.2%(p=0.30)。
- 长期随访(3.3±2.6年)复合终点24.2% vs 24.3%(p=0.97),同侧卒中3.7% vs 5.2%(p=0.32),TIA 5.1% vs 4.0%(p=0.50),MI 2.6% vs 3.6%(p=0.45),死亡17.5% vs 19.1%(p=0.58),再狭窄4.9% vs 7.2%(p=0.19),再干预2.5% vs 4.8%(p=0.08)。
- PSM队列中30天复合终点3.3% vs 2.2%(p=1.00),长期复合终点34.1% vs 31.9%(p=0.88),再狭窄4.4% vs 7.7%(p=0.54),再干预1.1% vs 6.6%(p=0.12)。
- 女性总胆固醇185.9±50.1 vs 158.1±43.4 mg/dL(p<0.01),HDL 56.8±18.1 vs 45.9±15.2 mg/dL(p<0.01),LDL 101.5±45.4 vs 86.3±38.0 mg/dL(p<0.01),LDL/HDL比值无显著差异。
临床怎么用
- 对于症状性颈动脉狭窄患者,选择CEA、TCAR或TFCAS时,性别不应作为独立影响短期或长期结局的因素。
- 女性患者血脂谱特征不同,但LDL/HDL比值无差异,降脂策略可参照通用指南。
- 具有易损斑块特征的高危患者,男女均可考虑血运重建,短期和长期结局相似。
局限性
- 回顾性研究设计。
- 仅对具备MRA血管壁成像的部分患者进行了倾向性评分匹配,样本量较小(N=182)。
- 随访时间3.3±2.6年,可能不足以评估更长期结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Sex-based differences in outcomes after carotid revascularization remain poorly defined in symptomatic patients. We aimed to compare short and long-term outcomes between men and women with symptomatic carotid artery disease who underwent carotid revascularization across a ten-year period in three stroke centers. METHODS: A retrospective study was conducted on a consecutive series of cases between 2016 and 2026. Cases included patients presenting with stroke, transient ischemic attack (TIA), or amaurosis fugax attributable to ipsilateral carotid artery stenosis within six months prior carotid endarterectomy (CEA), transcarotid artery revascularization (TCAR), or transfemoral carotid artery stenting (TFCAS). Patients with prior neck radiation were excluded. Primary outcomes were stroke, TIA, myocardial infarction (MI), and death within 30 days. Secondary outcomes included long-term stroke, TIA, MI, death, restenosis, and reintervention. Both primary and secondary outcomes were analyzed individually and as a composite endpoint. To account for sex-based differences and vulnerable plaque feature burden, a 1:1 propensity score-matched (PSM) analysis was performed among patients with available magnetic resonance angiography with vessel wall imaging (MRA-VWI). RESULTS: A total of 822 procedures were performed (men: 571, 69.5%; women: 251, 30.5%) with a mean age of 73.2 ± 9.2 years. Procedure distribution was similar between groups (CEA: 69.4% vs 70.9%; TCAR: 6.1% vs 5.6%; TFCAS: 24.5% vs 23.5%, p=0.89). Demographics and comorbidities were otherwise comparable between groups. Women had higher total cholesterol (185.9 ± 50.1 vs 158.1 ± 43.4 mg/dL, p<0.01), HDL (56.8 ± 18.1 vs 45.9 ± 15.2 mg/dL, p<0.01), and LDL (101.5 ± 45.4 vs 86.3 ± 38.0 mg/dL, p<0.01); however, the LDL/HDL ratio was not significant. Medication regimens were similar between groups, except estrogen use, which was exclusive to women (4.0%, p<0.01). Symptom presentation was comparable for stroke (49.0% vs 48.6%, p=0.91), TIA (32.0% vs 33.5%, p=0.69), and amaurosis fugax (22.1% vs 20.7%, p=0.67). At 30 days, the composite of stroke, TIA, MI, and death was similar (4.2% vs 4.0%, p=0.88), with no statistically significant differences in ipsilateral stroke (2.5% vs 1.6%, p=0.61), TIA (0.7% vs 1.6%, p=0.23), MI (0.5% vs 0.0%, p=0.25), or mortality (0.5% vs 1.2%, p=0.30). On long-term follow-up at 3.3 ± 2.6 years, the composite outcomes remained comparable (24.2% vs 24.3%, p=0.97), as were ipsilateral stroke (3.7% vs 5.2%, p=0.32), TIA (5.1% vs 4.0%, p=0.50), MI (2.6% vs 3.6%, p=0.45), mortality (17.5% vs 19.1%, p=0.58), restenosis (4.9% vs 7.2%, p=0.19), and reintervention rates (2.5% vs 4.8%, p=0.08). In the PSM cohort (men: 91, women: 91, N=182), the 30-day (3.3% vs 2.2%, p=1.00) and long-term (34.1% vs 31.9%, p=0.88) composite outcome of stroke, TIA, MI and death were similar. Restenosis (4.4% vs 7.7%, p=0.54), and reintervention (1.1% vs 6.6%, p=0.12) were also not statistically significantly different between groups. CONCLUSION: No statistically significant sex-based differences were identified in 30-day or long-term outcomes after CEA, TCAR, or TFCAS across a ten-year period at three high-volume stroke centers. Furthermore, on propensity score matching of our highest risk patient population with vulnerable plaque features did not affect their short- and long-term outcomes.
引用
- Esquetini-Vernon C, Meschia JF, Kumar G, et al. Sex-Based Outcomes After Carotid Artery Revascularization in Symptomatic Patients: A Multi-Center Cohort Study. Ann Vasc Surg. 2026. PMID: 42946305. doi:10.1016/j.avsg.2026.10.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。